Oramed Pharmaceuticals Inc. announced the appointment of Mr. Michael Rabinowitz to the newly created position of Chief Commercial Officer effective August 1, 2021. Mr. Rabinowitz will be responsible for the company's overall commercial strategy and execution. Mr. Rabinowitz is a highly accomplished commercial leader having spent over 20 years at the global biopharmaceutical company Merck & Co. serving in marketing, sales, business development, and financial leadership roles in the U.S. and globally.